tiprankstipranks
Newron Pharmaceuticals SpA (NWPHF)
OTHER OTC:NWPHF
Want to see NWPHF full AI Analyst Report?

Compare Newron Pharmaceuticals SpA (NWPHF) vs. Competitors

12 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Newron Pharmaceuticals SpA
$20.00
$364.19M
-9.69
113.68%
1 Buy
0 Hold
0 Sell
Moderate Buy
Molecular Partners AG
CHF3.41
CHF130.41M
-2.50
-4.01%
1 Buy
0 Hold
0 Sell
Moderate Buy
Basilea Pharmaceutica
CHF52.60
CHF669.55M
6.84
23.16%
1 Buy
0 Hold
0 Sell
Moderate Buy
Idorsia Ltd
CHF3.71
CHF988.01M
-4.80
194.84%
2 Buy
0 Hold
0 Sell
Moderate Buy
Santhera Pharmaceuticals Holding
CHF17.62
CHF248.30M
-4.06
29.70%
1 Buy
0 Hold
0 Sell
Moderate Buy
Xlife Sciences Ltd.
CHF22.90
CHF122.85M
3.95
0.95%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
NWPHF
Newron Pharmaceuticals SpA
20.00
10.64
113.68%
CH:MOLN
Molecular Partners AG
3.23
-0.21
-6.10%
CH:BSLN
Basilea Pharmaceutica
54.50
10.10
22.75%
CH:IDIA
Idorsia Ltd
3.89
2.61
203.35%
CH:SANN
Santhera Pharmaceuticals Holding
17.12
3.94
29.89%
CH:XLS
Xlife Sciences Ltd.
21.30
0.80
3.90%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts